Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

345
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
345
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

311
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
311
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

415
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
415
Pharmacovigilance01:19

Pharmacovigilance

1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
Ethics in Research01:56

Ethics in Research

25.3K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.3K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

810
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
810

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic clinical outcome assessments and the European Union's clinical trial regulation: Smoothing the path to friction?

Contemporary clinical trials communications·2026
Same author

What can be done to improve confidence and trust in the safety of the system for pharmaceutical products?

Current drug safety·2013
Same author

Public perceptions of the pharmaceutical industry and drug safety: implications for the pharmacovigilance professional and the culture of safety.

Drug safety·2009
Same author

Guiding principles of safety as a basis for developing a pharmaceutical safety culture.

Current drug safety·2008

Related Experiment Video

Updated: Dec 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Vulnerability and Clinical Research: Mapping the Challenges for Stakeholders.

Pierre Mermet-Bouvier1, Matthew D Whalen2

  • 1Datechsys, Courbevoie, France. pierremermetbouvier@gmail.com.

Therapeutic Innovation & Regulatory Science
|January 29, 2020
PubMed
Summary

This study identifies 15 categories of patient vulnerability across five challenges by analyzing international research protection documents. It offers a framework for stakeholders to enhance patient protections in clinical research, promoting inclusivity and ethical considerations.

Keywords:
Clinical researchEthicsInternational core documentsPatient protectionVulnerability

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K

Related Experiment Videos

Last Updated: Dec 29, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.1K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.4K

Area of Science:

  • Clinical Research Ethics
  • Regulatory Science
  • Patient Advocacy

Background:

  • International guidance expands on U.S. FDA Special Populations, highlighting diverse patient vulnerabilities.
  • Growing interest in vulnerable patient status and protections within the clinical research environment.
  • Analysis of 12 core international documents on human research protections identified references to vulnerable populations.

Discussion:

  • Identified 15 distinct categories of vulnerability, grouped into five challenge types.
  • Mapped regulatory and ethical interpretations to define vulnerability within the stakeholder ecosystem.
  • Proposed a "chain of protection" model for comprehensive patient safeguarding.

Key Insights:

  • Developed a multi-level mapping framework (macro, meso, micro) for understanding vulnerability.
  • Offers practical applications for stakeholders, including research sites and Ethics Committees/IRBs.
  • Emphasizes the importance of patient-centricity and diverse patient inclusion from discovery to real-world evidence (RWE).

Outlook:

  • Enhancing stakeholder understanding of patient diversity is crucial for ethical research.
  • Integrates "new science" and technological advances into patient protection strategies.
  • Advocates for education and training to ensure sensitivity in protocol development, informed consent, and privacy protection.